Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Alter, R. Sánchez-Pescador, M. Urdea, J. Wilber, R. Lagier, A. Bisceglie, J. Shih, P. Neuwald (1995)
Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNAJournal of Viral Hepatitis, 2
M. Piatak, M. Saag, L. Yang, S. Clark, J. Kappes, K. Luk, B. Hahn, G. Shaw, J. Lifson (1993)
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.Science, 259 5102
K. Murthy, D. Henrard, J. Eichberg, K. Cobb, M. Busch, J. Allain, H. Alter (1999)
Redefining the HIV‐infectious window period in the chimpanzee model: evidence to suggest that viral nucleic acid testing can prevent blood‐borne transmissionTransfusion, 39
A. Prince, Bernard HOROWITZt, Louis Baker, Richard SHULMANt, Harold Ralph, Jay Valinsky, Anthony Cundell, B. Brotman, Wolfgang Boehle, F. Rey, Marcel Piet, Henk Reesink, Nico Lelie, M. Tersmette, Frank Miedema, Luiz Barbosaii, George Nemoii, Chet Nastala, Jonathan ALLANtt, D. LEEtt (1988)
Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.Proceedings of the National Academy of Sciences of the United States of America, 85 18
M. Hijikata, Y. Shimizu, H. Kato, A. Iwamoto, J. Shih, H. Alter, R. Purcell, H. Yoshikura (1993)
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexesJournal of Virology, 67
P. Lelie, H. Drimmelen, H. Cuypers, S. Best, S. Stramer, C. Hyland, J. Allain, P. Moncharmont, C. Defer, M. Nübling, A. Glauser, Marcia Da Silva Cardoso, J. Viret, M. Lankinen, L. Grillner, U. Wirthmüller, J. Coste, V. Schottstedt, B. Masecar, E. Dax (2002)
Sensitivity of HCV RNA and HIV RNA blood screening assaysTransfusion, 42
G. Schreiber, M. Busch, S. Kleinman, J. Korelitz (1996)
The Risk of Transfusion-Transmitted Viral InfectionsThe New England Journal of Medicine, 334
J. Detmer, R. Lagier, J. Flynn, C. Zayati, J. Kolberg, M. Collins, M. Urdea, R. Sánchez-Pescador (1996)
Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technologyJournal of Clinical Microbiology, 34
F. Cao, Xuonling Shi, Yang Ji, Q. Ren, Yusen Zhou, Haitao Wang (2000)
Detection of TT Virus Infection in HCV‐Infected Blood Donors from Southwestern ChinaVox Sanguinis, 78
K. Müller-Breitkreutz (2000)
Results of Viral Marker Screening of Unpaid Blood Donations and Probability of Window Period Donations in 1997Vox Sanguinis, 78
P. Ulrich, R. Bhat, B. Seto, D. Mack, J. Sninsky, G. Vyas (1989)
Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees.The Journal of infectious diseases, 160 1
Couroucé Am, J. Pillonel (1996)
Transfusion-transmitted viral infections. Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion.The New England journal of medicine, 335 21
S. Sato, Wataru Ohhashi, H. Ihara, S. Sakaya, T. Kato, H. Ikeda (2001)
Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assayTransfusion, 41
M. Busch (2000)
HIV, HBV and HCV: new developments related to transfusion safety.Vox sanguinis, 78 Suppl 2
Couroucé Couroucé, Pillonel Pillonel (1996)
Transfusion‐transmitted viral infections.N Engl J Med, 335
Ai Ling, K. Robbins, Teresa Brown, Valerie Dunmire, S. Thoe, Sin-Yew Wong, Yee Leo, Diana Teo, James Gallarda, Bruce Phelps, Mary Chamberland, Michael Busch, T. Folks, Marcia Kalish (2000)
Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.JAMA, 284 2
M. Berninger, Marlene Hammer, B. Hoyer, J. Gerin (1982)
An assay for the detection of the dna genome of hepatitis b virus in serumJournal of Medical Virology, 9
BACKGROUND: Blood transfusion centers around the world have introduced minipool NAT to reduce the risk of HBV, HCV, and HIV transmission by blood donations drawn in the infectious window phase. What would be the reduction in the residual risk when minipool NAT would be replaced by single‐donation NAT? STUDY DESIGN AND METHODS: A mathematic model was developed to estimate the probability of virus transmission by blood transfusion when NAT screening methods are used for virologic safety testing. The major assumptions used are threefold: 1) The viral nucleic acid concentrations in the early window phase of infection double in 2.8 (HBV), 0.74 (HCV), and 0.90 (HIV) days. 2) The detectability of low copy numbers of viral DNA or RNA by the screening assay can be described with a probit model. 3) The probability of infection depends linearly on the logarithm of the administered dose, with 50‐percent infectivity rates at 10 (HBV and HCV) or 1000 (HIV) viral nucleic acid copies per transfusion unit (estimates based on NAT studies with samples of known infectivity in chimpanzees). RESULTS: A reasonably simple equation was obtained that allows studying the effect of the sensitivity of the NAT assay and of the pool size used for screening on the residual risk of transfusion‐transmitted infection. The computations are illustrated by using observed sensitivity estimates of various NAT methods. By using epidemiologic data among European donors over 1997 as baseline, the calculations predict that the incidence of virus transmission per 10‐million RBC transfusions reduces with the following numbers when lowering the test pool size from 96 to 1 (single‐donation testing): HBV from 11 to 13 to 3.3 to 5.1, HCV from 1.7 to 2.0 to 0.5 to 0.8, and HIV from 0.47 to 0.62 to 0.010 to 0.045 (ranges for the different NAT screening methods). CONCLUSION: A proper mathematic model for the calculation of residual infection risk by blood transfusion helps understand the impact of introducing new NAT methods for blood safety testing.
Transfusion – Wiley
Published: May 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.